Effect of fish diets and weight loss on serum leptin concentration in overweight, treated-hypertensive subjects

Journal of Hypertension

Volumn 22, Issue 10, 2004, Pages 1983-1990

  Mori, Trevor A ^a   Burke, Valerie ^a   Puddey, Ian B ^a   Shaw, Jonathan E ^b   Beilin, Lawrence J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Fish diet; Hypertension; Leptin; Weight loss; 3 fatty acids

Indexed keywords

INSULIN; LEPTIN; OMEGA 3 FATTY ACID;

ADIPOCYTE; ADULT; AGED; ARTICLE; BODY FAT; BODY WEIGHT; CALORIC RESTRICTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DIET; FEMALE; HEART RATE; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; WEIGHT REDUCTION;

EID: 5044223159     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200410000-00022     Document Type: Article

References (43)

1. Beilin LJ, Mori TA. Dietary omega-3 fatty acids In: Whelton PK, He J, Louis GT (editors): Lifestyle modification for the prevention and treatment of hypertension, New York: Marcel Dekker Inc.; 2003, pp. 275-300.
2. Geleijnse JM, Giltay EJ, Grobbee DE, Donders AR, Kok FJ. Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials. J Hypertens 2002;20:1493-1499.
3. Connor SL, Connor WE. Are fish oils beneficial in the prevention and treatment of coronary artery disease? Am J Clin Nutr 1997;66:1020S-1031S.
4. Mori TA, Beilin LJ. Long-chain omega 3 fatty acids, blood lipids and cardiovascular risk reduction. Curr Opin Lipidol 2001;12:11-17.
5. Bao DQ, Mori TA, Burke V, Puddey IB, Beilin LJ. Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight' hypertensives. Hypertension 1998;32:710-717.
6. Mori TA, Bao DQ, Burke V, Puddey IB, Watts GF, Beilin LJ. Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects. Am J Clin Nutr 1999;70:817-825.
7. Winnicki M, Somers VK, Accurso V, Phillips BG, Puato M, Palatini P, Pauletto P. Fish-rich diet, leptin, and body mass. Circulation 2002; 106:289-291.
8. Ahima RS, Flier JS. Leptin. Ann Rev Physiol 2000;62:413-437.
9. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 1995;1:1155-1161.
10. Considine RV, Sinha MK, Heiman ML Kriauciunas A, Stephens TW, Nyce MR, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295.
11. Soderberg S, Ahren B, Stegmayr B, Johnson O, Wiklund PG, Weinehall L, et al. Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. Stroke 1999;30:328-337.
12. Soderberg S, Ahren B, Jansson JH, Johnson O, Hallmans G, Asplund K, Olsson T. Leptin is associated with increased risk of myocardial infarction. J Intern Med 1999;246:409-418.
13. Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, Sattar N. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 2001; 104:3052-3056.
14. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS. Role of leptin in the neuroendocrine response to fasting. Nature 1996;382:250-252.
15. Boden G, Chen X, Mozzoli M, Ryan I. Effect of fasting on serum leptin in normal human subjects. J Clin Endocrinol Metab 1996;81:3419-3423.
16. Hynes GR, Heshka J, Chadee K, Jones PJ. Effects of dietary fat type and energy restriction on adipose tissue fatty acid composition and leptin production in rats. J Lipid Res 2003;44:893-901.
17. Trayhurn P, Thomas ME, Duncan JS, Rayner DV. Effects of fasting and refeeding on ob gene expression in white adipose tissue of lean and obese (oblob) mice. FEBS Letters 1995;368:488-490.
18. Widjaja A, Stratton IM, Horn R, Holman RR, Turner R, Brabant G. UKPDS 20:plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects. J Clin Endocrinol Metab 1997;82:654-657.
19. Mark AL, Correia MLG, Rahmouni K, Haynes WG. Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens 2002;20:1245-1250.
20. Raclot T, Groscolas R, Langin D, Ferre P. Site-specific regulation of gene expression by n-3 polyunsaturated fatty acids in rat white adipose tissues. J Lipid Res 1997;38:1963-1972.
21. Rojo-Martinez G, Soriguer FJ, Gonzalez-Romero S, Tinahones F, Moreno F, de Adana SR, et al. Serum leptin and habitual fatty acid dietary intake in patients with type 1 diabetes mellitus. Eur J Endocrino 2000; 142:263-268.
22. Cha MC, Jones PJ. Dietary fat type and energy restriction interactively influence plasma leptin concentration in rats. J Lipid Res 1998; 39:1655-1660.
23. Vandongen R, Mori TA, Burke V, Beilin LJ, Morris J, Ritchie J. Effects on blood pressure of omega 3 fats in subjects at increased risk of cardiovascular disease. Hypertension 1993;22:371-379.
24. Mori TA, Vandongen R, Beilin U, Burke V, Morris J, Ritchie J. Effects of varying dietary fat, fish, and fish oils on blood lipids in a randomized controlled trial in men at risk of heart disease. Am J Clin Nutr 1994; 59:1060-1068.
25. Lewis J, Holt R. NUTTAB 91-92. Nutrient tables for use in Australia. Canberra: National Food Authority; Australian Government Publishing Service, 1991.
26. Farooqi IS, Keogh JM, Kamath S, Jones S, Gibson WT, Trussell R, et al. Metabolism - Partial leptin deficiency and human adiposity. Nature 2001;414:34-35.
27. Friedman JM. The function of leptin in nutrition; Weight, and physiology. Nutr Rev 2002;60:S1-S14.
28. Correia MLG, Morgan DA, Sivitz WI, Mark AL, Haynes WG. Leptin acts in the central nervous system to produce dose-dependent changes in arterial pressure. Hypertension 2001;37:936-942.
29. Dunbar JC, Hu YG, Lu HQ. Intracerebroventricular leptin increases lumbar and renal sympathetic nerve activity and blood pressure in normal rats. Diabetes 1997;46:2040-2043.
30. Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR, et al. Neural mechanisms in human obesity-related hypertension. J Hypertens 1999;17:1125-1133.
31. Leibel RL, Rosenbaum M, Hirsch J. Changes in energy-expenditure resulting from altered body-weight. N Engl J Med 1995;332:621-628.
32. Reddy JK, Mannaerts GP. Peroxisomal lipid-metabolism. Ann Rev Nutr 1994;14:343-370.
33. Hashimoto M, Shinozuka K, Gamoh S, Tanabe Y, Hossain MS, Kwon YM, et al. The hypotensive effect of docosahexaenoic acid is associated with the enhanced release of ATP from the caudal artery of aged rats. J Nutr 1999;129:70-76.
34. Kawakami Y, Arai T, Okuda Y, Yamashita K. The regulation of obese (ob) gene expression by intracellular fatty acid concentration in adipocytes. Intern Med 1999;38:213-215.
35. Harris WS, n-3 Fatty acids and lipoproteins: Comparison of results from human and animal studies. Lipids 1996;31:243-252.
36. Reseland JE, Haugen F, Hollung K, Solvoll K, Halvorsen B, Brude IR, et al. Reduction of leptin gene expression by dietary polyunsaturated fatty acids. J Lipid Res 2001;42:743-750.
37. Clarke SD, Jump DB. Dietary polyunsaturated fatty-acid regulation of gene-transcription. Ann Rev Nutr 1994;14:83-98.
38. Kliewer SA, Sundseth SS, Jones SA, Brown PJ, Wisely GB, Koble CS, et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Nat Acad Sci (USA) 1997;94:4318-4323.
39. Peyron-Caso E, Taverna M, Guerre-Millo M, Veronese A, Pacher N, Slama G, Rizkalla SW. Dietary (n-3) polyunsaturated fatty acids up-regulate plasma leptin in insulin-resistant rats. J Nutr 2002;132:2235-2240.
40. Gregersen S, Thomsen JL, Jeppesen PB, Alstrup KK, Brock B, Pedersen SB, et al. Impact of dietary FA and energy restriction on plasma leptin and ob gene expression in mice. Lipids 2003;38:513-517.
41. Jang IS, Hwang DY, Chae KR, Lee JE, Kim YK, Kang TS, et al. Role of dietary fat type in the development of adiposity from dietary obesity-susceptible Sprague-Dawley rats. Br J Nutr 2003;89:429-437.
42. Remesar X, Rafecas I, Fernandez-Lopez JA, Alemany M. Is leptin an insulin counter-regulatory hormone? FEBS Letters 1997;402:9-11.
43. Segal KR, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 1996; 45:988-991.